FIR Capital
Praça Carlos Chagas, 49 - 7º andar, Belo Horizonte, Minas Gerais, 30170-020, Brazil
Overview
Founded in 1999, FIR Capital is a venture capital firm that invests in nascent, emerging or growing companies that demonstrate tremendous growth potential. FIR Capital looks for innovative projects and companies. It offers financial support, strategic advisory services and support to management, and assistance in hiring key executives, in addition to its experience in sales, marketing, innovation, controllership, exports, global expansion and strategic alliances. The partners of FIR Capital are venture capital pioneers in Brazil, having invested in Biobrás S.A. (later sold to Novo Nordisk), Miner Technology (sold to UOL) and Akwan Technology (sold to Google). In 2007, Draper Fisher Jurvetson (DFJ), one of the world´s biggest and best venture capital firms, acquired shareholding interest in FIR Capital. DFJ´s worldwide network spans 4 continents and consists of 23 venture capital funds, 135 investment professionals, more than 300 investors and investments in around 550 companies, with more than US$ 5.5 billion under its management. DFJ´s portfolio of success stories includes Hotmail, Skype, Baidu, DivX, Mobile365, Overture, 411 and EnerNOC.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 9
Investment portfolio
- ISA Saúde
Participated · Series A · Aug 2022
ISA Saúde operates a digital platform that enables hospital-level services to be delivered in patients’ homes, replacing care that would traditionally occur in brick-and-mortar facilities. The company coordinates a network of more than 4,000 healthcare professionals and currently treats roughly 1,500 patients per day across 60 Brazilian cities. By integrating structural clinical data and artificial intelligence, ISA Saúde seeks to generate predictive insights and streamline the patient journey. With fresh capital, the company intends to triple the number of cities it serves and broaden its range of care lines. Its tech-enabled model positions it to capture growing demand for convenient, cost-effective healthcare in Brazil. The business is financed by venture investors and most recently secured a US$30 million Series B round to fuel geographic and product expansion.